Region:Asia
Author(s):Geetanshi
Product Code:KRAC2328
Pages:90
Published On:October 2025

By Type:The market is segmented into various types, including DNA Library Preparation, RNA Library Preparation, Target Enrichment Kits, and Others. Among these, DNA Library Preparation is the leading sub-segment due to its extensive application in genomic research and clinical diagnostics. The increasing demand for high-throughput sequencing and the need for accurate genomic data are driving the growth of this segment. RNA Library Preparation is also gaining traction, particularly in transcriptomics studies, as researchers focus on understanding gene expression patterns.

By End-User:The end-user segmentation includes Academic Research Institutes, Pharmaceutical Companies, Clinical Laboratories, and Biotechnology Firms. Academic Research Institutes are the dominant segment, driven by the increasing number of research projects focusing on genomics and personalized medicine. Pharmaceutical companies are also significant users, utilizing sequencing technologies for drug development and biomarker discovery.

The APAC Next Generation Sequencing Library Preparation Market is characterized by a dynamic mix of regional and international players. Leading participants such as Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd (Roche Sequencing Solutions), QIAGEN N.V., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., BGI Genomics Co., Ltd., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., 10x Genomics, Inc., New England Biolabs, Inc., Takara Bio Inc., Beckman Coulter, Inc. (Danaher Corporation), Hamilton Company, Fluidigm Corporation, Revvity, Inc. (formerly PerkinElmer), Array Technologies, Inc., Genomatix Software GmbH, Dovetail Genomics contribute to innovation, geographic expansion, and service delivery in this space.
The future of the APAC NGS library preparation market appears promising, driven by ongoing technological advancements and increasing investments in genomics research. As automation and artificial intelligence become integral to library preparation processes, efficiency and accuracy are expected to improve significantly. Furthermore, the growing emphasis on personalized medicine and genetic testing will likely create new avenues for market expansion, fostering collaborations between academia and industry to enhance research capabilities and application development.
| Segment | Sub-Segments |
|---|---|
| By Type | DNA Library Preparation RNA Library Preparation Target Enrichment Kits Others |
| By End-User | Academic Research Institutes Pharmaceutical Companies Clinical Laboratories Biotechnology Firms |
| By Application | Oncology Infectious Diseases Genetic Disorders Others |
| By Distribution Channel | Direct Sales Online Sales Distributors Others |
| By Region | North Asia (China, Japan, South Korea) Southeast Asia (Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines) South Asia (India, Pakistan, Bangladesh, Sri Lanka) Oceania (Australia, New Zealand) |
| By Research Type | Basic Research Applied Research Clinical Research Others |
| By Sample Type | Blood Samples Tissue Samples Saliva Samples Others |
| By Sequencing Technology | Targeted Genome Sequencing Whole Genome Sequencing Whole Exome Sequencing Other Sequencing Types |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Clinical Research Laboratories | 45 | Laboratory Managers, Clinical Researchers |
| Genomic Testing Companies | 40 | Product Development Managers, R&D Directors |
| Academic Research Institutions | 40 | Principal Investigators, Genomics Professors |
| Biotechnology Firms | 40 | Business Development Managers, Technical Sales Representatives |
| Healthcare Providers | 35 | Pathologists, Genetic Counselors |
The APAC Next Generation Sequencing Library Preparation Market is valued at approximately USD 435 million, reflecting significant growth driven by advancements in genomic research, the rising prevalence of genetic disorders, and increasing demand for personalized medicine.